News

myMatrixx Experts Featured in Industry Publications After Release of 2020 Drug Trend Report


2020 Workers Compensation Drug Trend Report - Download Today

In articles for industry publications WCI Weekly and WorkersCompensation.com, myMatrixx experts highlighted some of the key takeaways from the newly released 2020 Drug Trend Report. This annual report provides an in-depth analysis of pharmaceutical data in the workers’ compensation sector.  In a post for WCI Weekly, myMatrixx Chief Clinical Officer Phil Walls was joined by …

Kloxxado Receives FDA Approval for Opioid Overdoses


The U.S. Food and Drug Administration (FDA) approved Kloxxado™ (naloxone) nasal spray, 8mg, on April 29, 2021. A higher strength than the currently available naloxone nasal sprays, it is indicated for emergency use to counteract the central nervous system (CNS) and respiratory depression associated with an overdose of opioids. Approved for children as well as …

myMatrixx Keeps Pressure on Spending and Identifies Key COVID-Related Effects in 2020 Drug Trend Report


In the wake of an unprecedented year for workers’ compensation pharmacy, myMatrixx was able to achieve positive outcomes, according to the newly released 2020 Drug Trend Report. Despite challenges that included the COVID-19 pandemic, an unpredictable environment for new claims and continuing issues such as the opioid misuse crisis, myMatrixx-managed plans saw a 2.6% reduction …

Phil Walls Discusses COVID-19 Presumption with Risk & Insurance


Even with signs that society is beginning to turn the corner on the pandemic, the workers’ compensation sector will be grappling with presumption laws around COVID-19 infection for years. That is the topic of a recent article for Risk & Insurance magazine that quotes myMatrixx Chief Clinical Officer Phil Walls and other industry experts. With …

myMatrixx Teams Up with Travelers for NWCDC Digital Session on Psychotropic Drugs


new drugs for workers compensation 2015

On Wednesday April 14, myMatrixx Chief Clinical Officer, Phil Walls, was joined by Marcos Iglesias MD, Chief Medical Director of the Travelers and Constitution State Services to discuss the interaction between behavioral health and chronic pain management in workers’ compensation. The presentation, Navigating the Intersection of Pain Management and Psychotropic Drugs, was held as part …